Surgical Site Infections at a West Cameroon Hospital
SSI Mbouo
Incidence, Microbial Spectrum and Risk Factors of Surgical Site Infections at a West Cameroon Hospital: A Prospective Cohort Study
1 other identifier
observational
148
1 country
1
Brief Summary
Surgical site infections (SSI) constitute an important health concern in low and middle income countries, leading to prolonged hospital stay and increased costs. Previous studies indicate that in Africa up to 1/3 of patients undergoing surgery may be affected by a postoperative infection. The development and implementation of context-specific SSI prevention guidelines is important to reduce this complication. To deploy efficient context-specific measures, data on epidemiology and microbiology of these infections are needed. This means to adapt the prevention measures to the context-specific risk factors for surgical site infections in resource-limited settings, and to give locally adapted recommendations on antimicrobial therapy based on local resistance patterns. However, data in this respect are scarce in low and middle income countries. This present study will contribute to the needed epidemiology and microbiology data on SSI in Cameroon. It will be carried out as a prospective cohort study at the Mbouo Protestant hospital in the West Region of Cameroon. The incidence, microbial spectrum and respective antimicrobial resistance of SSI as well as the risk factors of SSI will be systematically investigated. The study will include 300 patients at the Hôpital Protestant de Mbouo (HPM) who underwent surgery and gave their informed consent for inclusion, the timeframe is 04/2021 - 11/2021. An active SSI surveillance system will be put in place for 30 postoperative days to diagnose SSI. Expected outcomes: The incidence of SSI is likely to be higher than 10%. Concerning risk factors, preoperative bodywashing and perioperative antibioprophylaxis is expected to be protective against SSI. Up to 1/3 of SSI are expected to occur after hospital discharge. For the microbial spectrum, a high proportion of Staphylococcus aureus is likely to be found. For the antimicrobial resistance no estimation can be give as data is non-existent in that region from the literature.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 26, 2021
CompletedFirst Submitted
Initial submission to the registry
August 17, 2021
CompletedFirst Posted
Study publicly available on registry
August 24, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 4, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 4, 2022
CompletedMarch 16, 2022
March 1, 2022
9 months
August 17, 2021
March 15, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of Surgical Site Infections (SSI)
The incidence of SSI of all patients included in the study
04 / 2021 - 11 / 2021
Secondary Outcomes (3)
Risk factors of SSI
04 / 2021 - 11 / 2021
Microbial spectrum of SSI
04 / 2021 - 11 / 2021
Post-operative mortality
04 / 2021 - 11 / 2021
Study Arms (2)
Patients without SSI
Patients who underwent surgery and who developed a surgical site infection (SSI) during 30 days after surgery
Patients with SSI
Patients who underwent surgery and who didn't develop a surgical site infection (SSI) during 30 days after surgery
Interventions
No intervention is done, only observation of routine clinical practice
Eligibility Criteria
All patients that receive surgery at the Hôpital Protestant de Mbouo in Cameroon and that are willing and consenting to participate in the study
You may qualify if:
- Patient underwent surgery at the hospital during study period
You may not qualify if:
- Unconscious patients, mentally ill patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Christian Dolllead
- Charite University, Berlin, Germanycollaborator
Study Sites (1)
Hôpital Protestant de Mbouo
Bafoussam, West Region, 948, Cameroon
Related Publications (1)
Doll C, Ndoho Simo LC, Jeulefack H, Tamuedjoun Talom A, Kuate Kamdem L, Kenmogne JB, Djeunang Dongho GB, Trampuz A. Efforts in surgical site infection surveillance at the Mbouo Protestant Hospital in Cameroon. BMC Surg. 2025 Oct 3;25(1):419. doi: 10.1186/s12893-025-03229-5.
PMID: 41044533DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christian Doll, Dr
Université Evangélique du Cameroun, Cameroon; Hôpital Protestant de Mbouo, Cameroon; Charité University Medical Centre Berlin, Germany; University Medical Centre Jena, Germany
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 30 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Dr. med. Christian Doll
Study Record Dates
First Submitted
August 17, 2021
First Posted
August 24, 2021
Study Start
April 26, 2021
Primary Completion
February 4, 2022
Study Completion
February 4, 2022
Last Updated
March 16, 2022
Record last verified: 2022-03